Cargando…
Neurofilament light chain level is a weak risk factor for the development of MS
OBJECTIVE: To determine the prognostic value of selected biomarkers in clinically isolated syndromes (CIS) for conversion to multiple sclerosis (MS) and disability accrual. METHODS: Data were acquired from 2 CIS cohorts. The screening phase evaluated patients developing clinically definite MS (CIS-C...
Autores principales: | Arrambide, Georgina, Espejo, Carmen, Eixarch, Herena, Villar, Luisa M., Alvarez-Cermeño, José C., Picón, Carmen, Kuhle, Jens, Disanto, Giulio, Kappos, Ludwig, Sastre-Garriga, Jaume, Pareto, Deborah, Simon, Eva, Comabella, Manuel, Río, Jordi, Nos, Carlos, Tur, Carmen, Castilló, Joaquín, Vidal-Jordana, Angela, Galán, Ingrid, Arévalo, Maria J., Auger, Cristina, Rovira, Alex, Montalban, Xavier, Tintore, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027802/ https://www.ncbi.nlm.nih.gov/pubmed/27521440 http://dx.doi.org/10.1212/WNL.0000000000003085 |
Ejemplares similares
-
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis
por: Tur, Carmen, et al.
Publicado: (2022) -
Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013) -
Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2022) -
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2022) -
Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI
por: Coll, Llucia, et al.
Publicado: (2023)